Page 72 - MEMORIA ANUAL 2019 SEHH-FEHH

Programa EsPañol dE TraTamiEnTos En HEmaTología (PETHEma)
MEMORIA ANUAL 2019
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
• Versluis J, Cornelissen JJ, Craddock C, Sanz MA, Canaani J, Nagler A. Acute My- eloid Leukemia in Adults. In: Carreras E, Dufour C, Mohty M, et al. (editors). The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. pp. 507-21.
Presentaciones orales en congresos internacionales
• San Miguel J, Mateos MV, González V, Dimopoulos MA, Kastritis E, Hajek R, Fer- nández de Larrea Rodríguez C, Morgan GJ, Merlini G, Mangiacavalli S, Goldschmidt H, Cavo M, Kyriakou C, Qi M, Ukropec J, Weiss BM, Cameron C, Rajkumar SV, Durie BG, Kumar S. Updated risk stratification model for smoldering multiple myeloma (SMM) incorporating the revised IMWG diagnostic criteria. Annual Meeting of the American Society of Clinical Oncology (ASCO). Chicago, May 31-Jun 04, 2019. J Clin Oncol. 2019;37(15 Suppl):8000.
• Mateos MV, Martínez-López J, Rodríguez Otero P, González-Calle V, González MS, Oriol A, Gutiérrez NC, Paiva B, Ríos Tamayo R, Rosinol Dachs L, Álvarez MA, Calasanz MJ, Bargay J, González AP, Alegre Amor A, Escalante F, Íñigo B, Puig N, De La Ru- bia J, Teruel AI, Cedena Romero MT, De Arriba F, Palomera L, Hernández MT, López Jiménez J, Martín J, García Mateo A, Ocio EM, Bladé J, Lahuerta JJ, San-Miguel J. Curative strategy (GEM-CESAR) for high-risk smoldering myeloma: carfilzomib, lenalidomide and dexamethasone (KRD) as induction followed by HDT-ASCT, consolidation with KRD and maintenance with RD. 24th Congress of the Europe- an-Hematology-Association (EHA). Amsterdam, Jun 13-16). EHA Library. Mateos M. 06/15/19; 267454; S871.
• Botta C, Pérez Ruiz C, Goicoechea I, Puig N, Cedena MT, Cordón L, Zabaleta A, Burgos L, Maia C, Rodríguez S, Alignani D, Rodríguez I, Sarvide S, Vilas-Zornoza A, Lorenzo- Vivas E, Rosinol L, Oriol A, Blanchard MJ, Ríos Tamayo R, Sureda Balari A, Martínez R, Martín J, Bargay J, De La Rubia J, Rossi M, Tagliaferri P, Tassone P, Gentile M, Merino J, Prosper F, Orfao A, Mateos MV, Lahuerta JJ, Bladé J, San-Miguel J, Paiva B. Single-Cell Characterization of Multiple Myeloma (MM) Immune Microenvironment Identifies CD27-negative T cells as Potential Tumor-Reactive Lymphocytes. 17th International Myeloma Workshop. Boston, Sep 12-15, 2019. Clin Lymphoma Myeloma. 2019;19(10 Suppl):E351-E352. Abstract: OAB-85. Doi: https://doi.org/10.1016/j.clml.2019.09.581.
• Rosinol L, Hebraud B, Oriol A, Colin AL, Ríos Tamayo R, Hulin C, Blanchard MJ, Cai- llot D, Sureda Balari A, Hernández MT, Arnulf B, Mateos MV, Macro M, San-Miguel J,
72